Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Protocol for Desensitization to Atezolizumab and Bevacizumab After Severe Anaphylaxis in the Treatment of Lung Adenocarcinoma.
Gonzalez-Diaz SN, Villarreal-Gonzalez RV, De Lira-Quezada CE, Rocha-Silva GK, Oyervides-Juarez VM, Vidal-Gutierrez O. Gonzalez-Diaz SN, et al. J Investig Allergol Clin Immunol. 2021 Jun 22;31(3):265-267. doi: 10.18176/jiaci.0637. Epub 2020 Aug 26. J Investig Allergol Clin Immunol. 2021. PMID: 32856592 Free article. No abstract available.
Hypersensitivity Reactions to Taxanes: A Comprehensive and Systematic Review of the Efficacy and Safety of Desensitization.
Villarreal-González RV, González-Díaz S, Vidal-Gutiérrez O, Canel-Paredes A, de la Cruz-de la Cruz C, García-Campa M, López-Méndez A, Alvarado-Ruiz S, Castells M. Villarreal-González RV, et al. Among authors: vidal gutierrez o. Clin Rev Allergy Immunol. 2023 Oct;65(2):231-250. doi: 10.1007/s12016-023-08968-y. Epub 2023 Aug 17. Clin Rev Allergy Immunol. 2023. PMID: 37589840 Review.
Safety and oncological effectiveness after desensitization in patients with previous hypersensitivity reactions to chemotherapy.
Villarreal-González RV, Vidal-Gutiérrez O, Martínez-Moyano JA, Madrazo-Morales M, Sáenz-Cantú KS, Cadenas-García DE, Oyervides-Juárez VM, Noriega-Iriondo MF, Rodríguez-Niño P. Villarreal-González RV, et al. Among authors: vidal gutierrez o. J Oncol Pharm Pract. 2024 Aug 28:10781552241269766. doi: 10.1177/10781552241269766. Online ahead of print. J Oncol Pharm Pract. 2024. PMID: 39196645
Immune Checkpoint Inhibitors in Patients with Testicular Cancer: A Systematic Review.
Salazar-Mejía CE, Villarreal-González RV, Vidal-Gutiérrez O, de la Cruz-de la Cruz C, Guadarrama-Rendón E, Alvarado-Ruiz SA, Guerra-Garza AS, Quiroz-Huerta R, Salazar-Salazar KA, Alvarez-Villalobos NA. Salazar-Mejía CE, et al. Among authors: vidal gutierrez o. J Adolesc Young Adult Oncol. 2024 Dec 24. doi: 10.1089/jayao.2024.0056. Online ahead of print. J Adolesc Young Adult Oncol. 2024. PMID: 39718949 Review.
32 results